Overview

Clinical Studies of Gemcitabine-Oxaliplatin

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
These are Phase 2 single-arm studies of gemcitabine in combination with oxaliplatin in refractory or relapsing pediatric solid tumors.
Phase:
Phase 2
Details
Lead Sponsor:
Gustave Roussy, Cancer Campus, Grand Paris
Treatments:
Gemcitabine
Oxaliplatin